Varex Q4 FY24 revenue $206M; GAAP EPS loss $1.22, non-GAAP EPS $0.19

Varex Imaging Corp

2024-FY EPS reported -$1.17 revenue$811,000,000

GAAP net loss of $1.22 per diluted share; non-GAAP EPS of $0.19, down from $0.45 YoY.
Total revenue $206M in Q4 FY24, down 10% YoY; full-year revenue $811M.
Medical segment revenue $144M (-12% YoY); Industrial $61M (-4% YoY).
Ended FY24 with $213M cash and marketable securities; operating cash flow $26M in Q4.
Q1 FY25 guidance: revenue $195-215M, non-GAAP EPS -$0.05 to $0.10.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.